Tuberculosis is the world's leading infectious cause of death, killing more than one million people each year. When the ...

Swiss pharmaceutical firm Roche has advanced its antibiotic candidate, zosurabalpin, into Phase 3 clinical trials, ...

Biofilms are conglomerates of bacteria and other organisms, which are feared in medicine as well as other areas because they ...

In March, the journal Nature published the discoveries of two paradigm-breaking antimicrobial compounds in as many weeks: a ...

Discover why nails separate from the nail bed, what causes onycholysis, and how to treat this common but concerning nail ...

Babies and small children are prone to middle ear infections, which typically have to be treated with orally administered ...

Researchers have long known that glycosaminoglycan-binding proteins (HBPs) help control vital processes like cell growth, ...

Whakaihu Waka researchers have been part of two studies in the battle against drug resistant strains of Mycobacterium ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss drugmaker Roche announced it would advance the testing of an antibiotic against a ...

it would be the first new class of antibiotic capable of killing acinetobacter or any other “Gram-negative” bacteria to be developed for more than 50 years. This type of bug has a structure ...

Its unique structure could pave the way for antibiotics that bacteria have never encountered before," Jaime Felipe Guerrero-Garzón, study author from the University of Vienna's Department of ...